Osteopore Limited
Osteopore Limited (OSX.AX) Stock Competitors & Peer Comparison
See (OSX.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OSX.AX | A$0.01 | +0.00% | 1.9M | -0.60 | -A$0.01 | N/A |
| RMD.AX | A$32.21 | -1.59% | 46.9B | 22.06 | A$1.46 | +1.01% |
| FPH.AX | A$30.28 | -2.35% | 17.8B | 49.64 | A$0.61 | +1.38% |
| ANN.AX | A$28.51 | -0.56% | 4.1B | 21.28 | A$1.34 | +2.82% |
| NAN.AX | A$3.70 | -4.15% | 1.1B | 52.86 | A$0.07 | N/A |
| TTX.AX | A$4.34 | +3.09% | 220.3M | -10.85 | -A$0.40 | N/A |
| SDI.AX | A$1.25 | +0.00% | 148.6M | 12.50 | A$0.10 | +2.72% |
| AHC.AX | A$0.34 | -1.47% | 125.5M | 16.75 | A$0.02 | N/A |
| TRJ.AX | A$0.41 | +2.50% | 62.6M | -41.00 | -A$0.01 | N/A |
Stock Comparison
OSX.AX vs RMD.AX Comparison April 2026
OSX.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSX.AX stands at 1.9M. In comparison, RMD.AX has a market cap of 46.9B. Regarding current trading prices, OSX.AX is priced at A$0.01, while RMD.AX trades at A$32.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSX.AX currently has a P/E ratio of -0.60, whereas RMD.AX's P/E ratio is 22.06. In terms of profitability, OSX.AX's ROE is +3.46%, compared to RMD.AX's ROE of +0.25%. Regarding short-term risk, OSX.AX is more volatile compared to RMD.AX. This indicates potentially higher risk in terms of short-term price fluctuations for OSX.AX.Check RMD.AX's competition here